Evidence map›Paper›PMID 9311924›Full record

ArticleScience (New York, N.Y.)1997

Addiction is a brain disease, and it matters.

A I Leshner

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01015170 (The STOP Study), which is not on this map. Cited by 384 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
384citing papers in PubMed, 5 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01015170 phase4completednot on this mapstarted 2009, after this paper: background citation

The STOP Study: Real World Effectiveness of Zyban Treatment in a Clinical Population

TypeinterventionalSponsorCentre for Addiction and Mental HealthRan2009 to 2015Enrolled454ConditionsCigarette Smoking, Nicotine Addiction, Smoking CessationArmsbupropion HCl
3 · Its place in the literature

Who cites it

384 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,552 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. What is the Addictive Potential from Vaping?Nordisk alkohol- & narkotikatidskrift : NAT · 2026
    Article
  15. The neurobiological cravings signature (NCS) as a predictive neuromarker of clinical outcomes in alcohol use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  16. Article
  17. Anterior Insula Activity during Alcohol and Social Reward Self-Administration and Choice in Male and Female Rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  18. Article
  19. Article
  20. Article

324 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

A I LeshnerNational Institute on Drug Abuse, National Institutes of Health, 5600 Fishers Lane, Room 10-05, Rockville, MD 20857, USA. leshner@nih.gov
National Institute on Drug Abuse · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scientific advances over the past 20 years have shown that drug addiction is a chronic, relapsing disease that results from the prolonged effects of drugs on the brain. As with many other brain diseases, addiction has embedded behavioral and social-context aspects that are important parts of the disorder itself. Therefore, the most effective treatment approaches will include biological, behavioral, and social-context components. Recognizing addiction as a chronic, relapsing brain disorder characterized by compulsive drug seeking and use can impact society's overall health and social policy strategies and help diminish the health and social costs associated with drug abuse and addiction.

Indexed as

Substance-Related DisordersBehavior, AddictiveBrainBrain DiseasesChronic DiseaseHealth PolicyHumansPublic HealthRecurrenceSocial Problems

Identifiers

PMID9311924
OpenAlexW2157383890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.